Berberine Has My Attention, But There’s a Catch | Vascular Surgeon Reacts

Summary

Dr. Lily Johnston responds to Dr. Brewer’s discussion of berberine, weighing its potential effects on blood sugar and cardiovascular risk against the limits of the evidence. The central takeaway is that berberine may be useful for some people—particularly those with impaired glucose regulation—but it is not a substitute for lifestyle changes or prescribed treatment. Its benefits and risks should be assessed individually.

Potential benefits and evidence

• Berberine has been studied for blood-sugar control. An earlier, small study described in the video found that, after 13 weeks, participants with type 2 diabetes who took berberine had an A1C reduction similar to that of participants taking metformin.
• Dr. Brewer describes berberine as activating AMPK, a cellular energy-sensing pathway, with much of its activity occurring in the liver. He also discusses possible effects on triglycerides and other cardiovascular risk markers.
• Johnston notes that improved insulin sensitivity commonly lowers triglycerides, so this result may reflect a broader metabolic effect rather than a cholesterol-specific one.
• A newer study discussed in the video involved 84 men taking either 500 mg of berberine twice daily or a placebo for 12 weeks. Researchers measured blood proteins and then looked for a related pattern in a large biobank. The reported analysis associated that pattern with lower rates of heart disease and diabetes.
• Johnston urges caution in interpreting those findings. The study used a protein “fingerprint” that distinguished berberine from placebo only about 61% of the time, included men only, and did not show that berberine prevents heart attacks or other clinical events. She also questions whether the study’s Mendelian-randomization approach can support conclusions about taking a supplement.
• Both speakers emphasize that changing a biomarker is not the same as proving a reduction in disease outcomes. Berberine should not be assumed to replace medications such as metformin or statins.

Practical guidance and cautions

• Start with the foundations: Johnston emphasizes nutrition, movement, and addressing barriers to healthy habits before relying on supplements. Dr. Brewer recommends testing rather than guessing, reducing carbohydrate intake, increasing exercise intensity, and removing obstacles to progress.
• Use measurements to guide decisions: The video encourages tracking relevant markers—such as glucose responses, insulin resistance, and lipid measures—with a clinician rather than assuming a supplement is working.
• A regimen described by Dr. Brewer: He says he takes 500 mg of berberine about 30 minutes before a meal, often alongside fenugreek seed extract and alpha-lipoic acid. He says fenugreek may improve absorption and alpha-lipoic acid may help with inflammation.
• Johnston’s qualifications: She questions whether increasing absorption is necessary, since the evidence discussed involved regular berberine. She adds that dihydroberberine may cause less gastrointestinal upset and that the proposed role of alpha-lipoic acid merits separate discussion.
• Watch for side effects and interactions: Berberine can cause gastrointestinal problems, especially at higher doses. The video also warns that it may affect liver enzymes that process some statins, blood thinners, antiarrhythmics, and antidepressants, potentially changing medication levels. Anyone taking prescription drugs should consult a knowledgeable clinician before using it.
• “Natural” does not mean risk-free: The speakers caution against treating supplements as harmless or assuming supplement marketing is reliable. They recommend being clear about the goal, checking whether it can be measured, and reviewing the evidence independently.
• Consider the whole clinical picture: Johnston notes that metabolic problems may go undetected and that risk accumulated over many years may not disappear immediately when current markers improve. She also stresses meeting patients where they are: lifestyle changes are foundational, but other tools may be appropriate when lifestyle efforts are insufficient, impractical, or too slow for a person’s circumstances.

Presenters and sources

• Presenters: Dr. Lily Johnston, vascular surgeon and host/reactor; Dr. Brewer, whose berberine video is reviewed.
• Studies and sources mentioned: The March 2026 study titled “Berberine signature in cardiometabolic diseases using randomized controlled trial, cohort study, and Mendelian randomization”; an earlier study comparing berberine with metformin in people with newly diagnosed type 2 diabetes; the UK Biobank; and research by Singh and colleagues at Johns Hopkins on the diagnosis and treatment of metabolic disease.